Neoadjuvant therapy for pancreatic cancer: a current review.
The optimal therapy for pancreatic cancer continues to evolve. Neoadjuvant chemoradiation is a key component of current treatment regimens, and evaluation of previous treatment options will help guide future trials. Here the authors present a review of the current literature with discussion of future directions.
Abbott
Daniel E
DE
Department of Surgery, Northwestern University/Feinberg School of Medicine, Chicago, Illinois, USA. abbottdaniel7@gmail.com
Baker
Marshall S
MS
Talamonti
Mark S
MS
D000970:Antineoplastic Agents / Q000008:administration & dosage; D006801:Humans; D020360:Neoadjuvant Therapy; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D018714:Radiotherapy, Adjuvant
D000970:Antineoplastic Agents